Active · per the CBE, 17 November 2026

ZimPharma

BE1008117931

Rechtspersoon Besloten Vennootschap van publiek recht 1 establishment

ZimPharma is registered with the CBE as active in: Activiteiten van adviesbureaus op het gebied van bedrijfsvoering en overig managementadvies. Besloten Vennootschap van publiek recht, started on 8 April 2024, 1 establishment.

Rittwegerstraat 7A box 3, 1180 Ukkel

Behind the company: Audrey Zimmermann.

Active for

2 year, 7 months

Financials

Financial year 2026

ZimPharma from Ukkel, company number BE1008117931, closed financial year 2026 with a result of € 67,653 after tax. For that financial year ZimPharma recorded a gross margin of € 88,026 and equity of € 123,246. Compared with financial year 2025, the result moved from € 53,593 to € 67,653. Profitable, and profit is growing. The buffer is growing. A strong own buffer against the debts. The most recent annual accounts were filed with the National Bank of Belgium on October 30, 2026.

What it is worth Growing

€ 123,246

▲ 122% vs 2025

Assets minus debts, by the books. What is left if everything were sold and paid today.

Profit Growing

€ 67,653

▲ 26% vs 2025

Profit after tax over the fiscal year.

Cash in the bank

€ 110,392

▲ 132% vs 2025

Cash and bank balances on the last day of the fiscal year.

Where the profit goes Growing

Stays in the company

No dividend for 2026. Retained profit grew to € 121,246.

People and assets in 2026

Full-time equivalents estimate

≈ 1

No payroll staff. One director, so that person most likely runs the business.

Vehicles and equipment

€ 982

▼ 34% vs 2025

Book value of vehicles, furniture and equipment.

Debts at end 2026

Bank debt

None

No bank loans on the last day of the fiscal year.

Owed to suppliers

€ 42,860

▲ € 41,806 vs 2025

Supplier invoices still open on the last day of the fiscal year.

Taxes

€ 26,884

▲ 16% vs 2025

Corporate tax and VAT still to pay. No wage debt: nothing outstanding to staff or social security.

Key figures per fiscal year
20252026Change 2025 → 2026
Gross margin € 68,900 € 88,026 ▲ 28%
Profit after taxes € 53,593 € 67,653 ▲ 26%
Equity € 55,593 € 123,246 ▲ 122%
Total debts € 26,521 € 69,859 ▲ 163%
Cash € 47,518 € 110,392 ▲ 132%
Land & buildings € 1,504 € 1,351 ▼ 10%
Retained profit € 53,593 € 121,246 ▲ 126%
Balance sheet total € 82,114 € 193,106 ▲ 135%

By gross margin, ZimPharma ranks 458th of 1323 companies with main activity “Activiteiten van adviesbureaus op het gebied van bedrijfsvoering en overig managementadvies” in Ukkel that publish figures (fiscal year 2026).

Key figures of ZimPharma, fiscal years 2025 to 2026, from the annual accounts filed with the National Bank of Belgium.Next annual account (fiscal year 2027) expected before 31 October 2027.

What happened to ZimPharma?

What happened at ZimPharma in recent years, according to the Belgian Official Gazette, the CBE and the National Bank:

  • New annual accounts for financial year 2026: profit of € 67,653 (▲ 26% vs 2025). Source: NBB ↗
  • New establishment in Ukkel. KBO
  • Audrey Zimmermann became a director. NBB
  • Start of the company according to the CBE. KBO

In short

From € 53,593 profit in 2025 to € 67,653 profit in 2026.

Paid € 33,093 in corporate taxes since 2025.

Best year ever: 2026, with € 67,653 profit.

Management

Audrey Zimmermann
ZimPharma

Behind ZimPharma is Audrey Zimmermann.

Directors

According to the 2026 annual accounts

Audrey Zimmermann

Director

since 2024

Establishments

Establishment units

Physical locations of this company

Registered office

Rittwegerstraat 7A box 3

1180 Ukkel

Who else lives here?

A building full of entrepreneurs or one very busy letterbox? Another 1 companies are registered at this address.

All companies at this address →

What is an establishment unit? An establishment unit is a geographically identifiable place where activities of the enterprise are carried out.

Similar companies in Ukkel

Same main activity (Activiteiten van adviesbureaus op het gebied van bedrijfsvoering en overig managementadvies), 1535 active companies in Ukkel, largest first.

P2HFINANCES

€ 15.4 million gross margin · 2025

CAMERON CONSULTING

€ 11.6 million gross margin · 2026

Guy Pariente Holding

€ 5.2 million revenue · 2025

NUWA

€ 4.2 million gross margin · 2025

SATELLIT

€ 3.9 million gross margin · 2025

Fritz & C°

€ 3.7 million gross margin · 2025

Details

Company number
1008.117.931
VAT number
BE 1008.117.931
Registered office
Rittwegerstraat 7A bus 3, 1180 Ukkel
Names & denominations
ZimPharma
Enterprise type
Rechtspersoon
Legal form
Besloten Vennootschap van publiek recht
Legal situation
Normale toestand
Start date
8 April 2024
Peppol
Active · Active since 5 Jan 2026
Activities · NACE

Activiteiten van adviesbureaus op het gebied van bedrijfsvoering en overig managementadvies

Overige adviesbureaus op het gebied van bedrijfsbeheer; adviesbureaus op het gebied van bedrijfsvoering

Overige activiteiten van vrije beroepen en andere wetenschappelijke en technische activiteiten, neg

Overige gespecialiseerde wetenschappelijke en technische activiteiten

Frequently asked questions

What does ZimPharma do?
ZimPharma is registered with the CBE as active in: Activiteiten van adviesbureaus op het gebied van bedrijfsvoering en overig managementadvies. Besloten Vennootschap van publiek recht, started on 8 April 2024, 1 establishment.
What is the address of ZimPharma?
The registered office of ZimPharma is located at Rittwegerstraat 7A box 3, 1180 Ukkel.
Is ZimPharma still active?
Yes. According to the CBE (17 November 2026) ZimPharma is active, legal situation “Normale toestand”, started on 8 April 2024.
Is ZimPharma registered on Peppol?
Yes, ZimPharma is registered on the Peppol network with ID 0208:1008117931.
What is the enterprise number of ZimPharma?
The enterprise number of ZimPharma is BE1008117931.
When was ZimPharma founded?
ZimPharma was founded on 8 April 2024.